A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
Clinical trial NCT06245941 · TERMINATED
Trial details
- NCT number
- NCT06245941
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2025-12-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.